Martin Capital Partners LLC Has $331,000 Stake in The Clorox Company (NYSE:CLX)

Martin Capital Partners LLC lowered its position in The Clorox Company (NYSE:CLX) by 89.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,035 shares of the company’s stock after selling 17,561 shares during the quarter. Martin Capital Partners LLC’s holdings in Clorox were worth $331,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Mizuho Securities USA LLC lifted its stake in Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Ilex Capital Partners UK LLP boosted its stake in shares of Clorox by 512.7% during the 3rd quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock worth $88,315,000 after acquiring an additional 453,624 shares during the period. International Assets Investment Management LLC increased its holdings in shares of Clorox by 424.9% during the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after acquiring an additional 435,971 shares during the last quarter. Boston Trust Walden Corp raised its stake in Clorox by 5,442.5% in the 3rd quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock valued at $44,622,000 after acquiring an additional 268,966 shares during the period. Finally, Assenagon Asset Management S.A. lifted its holdings in Clorox by 302.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock valued at $57,390,000 after purchasing an additional 265,455 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on CLX shares. Barclays cut their target price on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research note on Friday, January 17th. Wells Fargo & Company upped their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday. Finally, DA Davidson cut their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Hold” and a consensus price target of $157.50.

Clorox Stock Performance

Shares of CLX stock opened at $148.29 on Wednesday. The business’s 50-day moving average price is $162.25 and its 200-day moving average price is $158.76. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $18.36 billion, a price-to-earnings ratio of 51.67, a PEG ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period in the previous year, the company posted $2.16 earnings per share. Equities research analysts forecast that The Clorox Company will post 6.86 EPS for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.29%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is presently 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.